TuHURA Biosciences Semi Variance
| HURA Stock | | | 2.32 0.18 8.41% |
Semi-variance provides a good measure of downside volatility for equity or a portfolio. It is similar to variance, but it only looks at periods where the returns are less than the target or average level. Below is TuHURA Biosciences's current Semi Variance with peer comparisons and related risk metrics.
Current Semi Variance Value
The current Semi Variance of 30.9 places TuHURA Biosciences at elevated price variability. This places TuHURA Biosciences toward the higher end of the volatility range for Biotechnology.
Semi Variance | = | SUM(RET DEV)2N(ZERO) |
| = | 30.9 | |
| SUM | = | Summation notation |
| RET DEV | = | Actual return deviation over selected period |
| N(ZERO) | = | Number of points with returns less than zero |
Semi Variance Peers Comparison
TuHURA Biosciences falls above the 20.04 peer average for Semi Variance. Cognition Therapeutics leads at 54.9 while Spero Therapeutics registers the lowest at 5.78. TuHURA Biosciences has exhibited greater price dispersion than the peer average over the measured period.
Semi Variance Relative To Other Indicators
The chart below plots Semi Variance against Maximum Drawdown for TuHURA Biosciences and its peers. Each point represents one equity — position along the horizontal axis shows Semi Variance while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
TuHURA Biosciences's Maximum Drawdown of
75.53 runs about
2.44 times its Semi Variance of
30.90 . This indicates Maximum Drawdown is significantly higher than Semi Variance for TuHURA Biosciences.
Methodology, Assumptions & Data Sources
TuHURA Biosciences has a current Semi Variance reading of 30.9. Semi Variance for TuHURA Biosciences is derived by applying a defined formula to historical price observations, producing a time-series of comparable readings. All inputs are based on exchange-reported closing prices, with adjustments for stock splits, dividends, and other corporate actions. TuHURA Biosciences operates in the health care sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. Indicator accuracy depends on data continuity across the calculation period. Gaps in trading history may affect the output.
Other Technical Indicators